Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jireh Y. Tan"'
Autor:
Xin Hui S Chan, Yan Naung Win, Ilsa L Haeusler, Jireh Y Tan, Shanghavie Loganathan, Sompob Saralamba, Shu Kiat S Chan, Elizabeth A Ashley, Karen I Barnes, Rita Baiden, Peter U Bassi, Abdoulaye Djimde, Grant Dorsey, Stephan Duparc, Borimas Hanboonkunupakarn, Feiko O Ter Kuile, Marcus V G Lacerda, Amit Nasa, François H Nosten, Cyprian O Onyeji, Sasithon Pukrittayakamee, André M Siqueira, Joel Tarning, Walter R J Taylor, Giovanni Valentini, Michèle van Vugt, David Wesche, Nicholas P J Day, Christopher L-H Huang, Josep Brugada, Ric N Price, Nicholas J White
Publikováno v:
PLoS Medicine, Vol 17, Iss 3, p e1003040 (2020)
BackgroundElectrocardiographic QT interval prolongation is the most widely used risk marker for ventricular arrhythmia potential and thus an important component of drug cardiotoxicity assessments. Several antimalarial medicines are associated with QT
Externí odkaz:
https://doaj.org/article/8ea6d1a043354012a21da11481816ea6
Autor:
Michèle van Vugt, Marcus V. G. Lacerda, PU Bassi, Amit Nasa, Rita Baiden, Feiko O. ter Kuile, Karen I. Barnes, Xin Hui S Chan, Stephan Duparc, Giovanni Valentini, Nicholas P. J. Day, Cyprian O. Onyeji, Yan Naung Win, Sasithon Pukrittayakamee, Shu Kiat S. Chan, Elizabeth A. Ashley, Nicholas J. White, Christopher L.-H. Huang, François Nosten, Walter R. J. Taylor, Josep Brugada, Joel Tarning, André Siqueira, Ilsa L. Haeusler, Sompob Saralamba, Borimas Hanboonkunupakarn, David Wesche, Grant Dorsey, Jireh Y. Tan, Ric N. Price, Abdoulaye Djimde, Shanghavie Loganathan
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 17, Iss 3, p e1003040 (2020)
PLoS medicine, 17(3). Public Library of Science
PLoS Medicine, Vol 17, Iss 3, p e1003040 (2020)
PLoS medicine, 17(3). Public Library of Science
Background Electrocardiographic QT interval prolongation is the most widely used risk marker for ventricular arrhythmia potential and thus an important component of drug cardiotoxicity assessments. Several antimalarial medicines are associated with Q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::769584c6e2b8c9d1327e1bdb58f4c8a3
https://www.repository.cam.ac.uk/handle/1810/303097
https://www.repository.cam.ac.uk/handle/1810/303097
Publikováno v:
The Lancet. Infectious Diseases
Summary Background Dihydroartemisinin–piperaquine is an effective and well tolerated artemisinin-based combination therapy that has been assessed extensively for the prevention and treatment of malaria. Piperaquine, similar to several structurally
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02dec67cec382e67c1d801391dfc7f60
https://doi.org/10.1016/s1473-3099(18)30297-4
https://doi.org/10.1016/s1473-3099(18)30297-4